3 research outputs found
Aceriphyllum rossii Extract and Its Active Compounds, Quercetin and Kaempferol Inhibit IgE-mediated Mast Cell Activation and Passive Cutaneous Anaphylaxis
Aceriphyllum rossii contains an abundant source of
natural flavonoids with potential antioxidant, anticancer and anti-inflammatory
properties. However, the effect of A. rossii extract (ARE) on immunoglobulin EÂ(IgE)-mediated allergic responses
remains unknown. In the present study, the effects of ARE and its
active compounds, quercetin and kaempferol, on IgE-mediated rat basophilic
leukemia mast cell activation and passive cutaneous anaphylaxis (PCA)
were investigated. ARE, quercetin, and kaempferol inhibited secretion
of β-hexosaminidase and histamine, and reduced the production
and mRNA expression of interleukin-4 and tumor necrosis factor-α.
ARE also decreased the production of prostaglandin E<sub>2</sub> and
leukotriene B<sub>4</sub> and expression of cyclooxygenase 2 and 5-lipoxygenase.
Furthermore, ARE, quercetin, and kaempferol inhibited IgE-mediated
phosphorylation of Syk, phospholipase Cγ, protein kinase C (PKC)Âμ,
and the mitogen-activated protein kinases, extracellular signal-regulated
kinase, p38, and c-Jun N-terminal kinase. ARE, quercetin, and kaempferol
markedly suppressed mast cell-dependent PCA in IgE-sensitized mice.
These results indicate that ARE and its active constituents, quercetin
and kaempferol, may be a useful therapy for immediate-type hypersensitivity
Asymmetric Ene-Reduction of α,β-Unsaturated Compounds by F<sub>420</sub>-Dependent Oxidoreductases A Enzymes from Mycobacterium smegmatis
The stereoselective reduction of alkenes conjugated to
electron-withdrawing
groups by ene-reductases has been extensively applied to the commercial
preparation of fine chemicals. Although several different enzyme families
are known to possess ene–reductase activity, the old yellow
enzyme (OYE) family has been the most thoroughly investigated. Recently,
it was shown that a subset of ene-reductases belonging to the flavin/deazaflavin
oxidoreductase (FDOR) superfamily exhibit enantioselectivity that
is generally complementary to that seen in the OYE family. These enzymes
belong to one of several FDOR subgroups that use the unusual deazaflavin
cofactor F420. Here, we explore several enzymes of the
FDOR-A subgroup, characterizing their substrate range and enantioselectivity
with 20 different compounds, identifying enzymes (MSMEG_2027 and MSMEG_2850)
that could reduce a wide range of compounds stereoselectively. For
example, MSMEG_2027 catalyzed the complete conversion of both isomers
of citral to (R)-citronellal with 99% ee, while MSMEG_2850
catalyzed complete conversion of ketoisophorone to (S)-levodione with 99% ee. Protein crystallography combined with computational
docking has allowed the observed stereoselectivity to be mechanistically
rationalized for two enzymes. These findings add further support for
the FDOR and OYE families of ene-reductases displaying general stereocomplementarity
to each other and highlight their potential value in asymmetric ene-reduction
Leaves of Persimmon (Diospyros kaki Thunb.) Ameliorate <i>N</i>‑Methyl‑<i>N</i>‑nitrosourea (MNU)-Induced Retinal Degeneration in Mice
The
purpose of the study was to investigate the protective effects
of the ethanol extract of Diospyros kaki (EEDK) persimmon leaves to study <i>N</i>-methyl-<i>N</i>-nitrosourea (MNU)-induced retinal degeneration in mice.
EEDK was orally administered after MNU injection. Retinal layer thicknesses
were significantly increased in the EEDK-treated group compared with
the MNU-treated group. The outer nuclear layer was preserved in the
retinas of EEDK-treated mice. Moreover, EEDK treatment reduced the
MNU-dependent up-regulation of glial fibrillary acidic protein (GFAP)
and nestin expression in Müller and astrocyte cells. EEDK treatment
also inhibited MNU-dependent down-regulation of rhodopsin expression.
Quercetin exposure significantly attenuated the negative effects of
H<sub>2</sub>O<sub>2</sub> in R28 cells, suggesting that quercetin
can act in an antioxidative capacity. Thus, EEDK may be considered
as an agent for treating or preventing degenerative retinal diseases,
such as retinitis pigmentosa and age-related macular degeneration